FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3204954837> ?p ?o ?g. }

• W3204954837 endingPage "865" @default.
• W3204954837 startingPage "856" @default.
• W3204954837 abstract "Enhanced postruminal supply of methionine (Met) during the peripartal period alters protein abundance of insulin, AA, and antioxidant signaling pathways in subcutaneous adipose tissue (SAT). Whether SAT is directly responsive to supply of Met and can induce molecular alterations is unknown. Our objective was to examine whether enhanced Met supply during an oxidative stress challenge in vitro alters insulin, AA, inflammation, and antioxidant signaling-related protein networks. Four late-lactation Holstein cows (average 27.0 kg of milk per day) were used for SAT collection. Tissue was incubated in duplicate for 4 h in a humidified incubator with 5% CO2 at 37°C according to the following experimental design: control medium with an ideal profile of essential AA (CTR; Lys:Met 2.9:1), CTR plus 100 μM H2O2 (HP), or CTR with greater Met supply plus 100 μM H2O2 (HPMET; Lys:Met 2.5:1). Molecular targets associated with insulin signaling, lipolysis, antioxidant nuclear factor, erythroid 2 like 2 (NFE2L2), inflammation, and AA metabolism were determined through reverse-transcription quantitative PCR and western blotting. Data were analyzed using the MIXED procedure of SAS 9.4 (SAS Institute Inc.). Among proteins associated with insulin signaling, compared with CTR, HP led to lower abundance of phosphorylated AKT serine/threonine kinase (p-AKT) and solute carrier family 2 member 4 (SLC2A4; insulin-induced glucose transporter). Although incubation with HPMET restored abundance of SLC2A4 to levels in the CTR and upregulated abundance of fatty acid synthase (FASN) and phosphorylated 5'-prime-AMP-activated protein kinase (p-AMPK), it did not alter p-AKT, which remained similar to HP. Among proteins associated with AA signaling, compared with CTR, challenge with HP led to lower abundance of phosphorylated mechanistic target of rapamycin (p-MTOR), and HPMET did not restore abundance to CTR levels. Among inflammation-related targets studied, incubation with HPMET led to greater protein abundance of nuclear factor kappa B subunit p65 (NFKB-RELA). The response in NFKB observed with HPMET was associated with a marked upregulation of the antioxidant transcription regulator NFE2L2 and the antioxidant enzyme glutathione peroxidase 1 (GPX1). No effects of treatment were detected for mRNA abundance of proinflammatory cytokines or antioxidant enzymes, underscoring the importance of post-transcriptional regulation. Overall, data indicated that short-term challenge with H2O2 was particularly effective in reducing insulin and AA signaling. Although a greater supply of Met had little effect on those pathways, it seemed to restore the protein abundance of the insulin-induced glucose transporter. Overall, the concomitant upregulation of key inflammation and antioxidant signaling proteins when a greater level of Met was supplemented to oxidant-challenged SAT highlighted the potential role of this AA in regulating the inflammatory response and oxidant status. Further studies should be conducted to assess the role of postruminal supply of Met and other AA in the regulation of immune, antioxidant, and metabolic systems in peripartal cow adipose tissue." @default.
• W3204954837 created "2021-10-11" @default.
• W3204954837 creator A5016532599 @default.
• W3204954837 creator A5029951659 @default.
• W3204954837 creator A5040338868 @default.
• W3204954837 creator A5043366961 @default.
• W3204954837 creator A5050699503 @default.
• W3204954837 creator A5054909901 @default.
• W3204954837 creator A5068100919 @default.
• W3204954837 creator A5078504589 @default.
• W3204954837 creator A5080118809 @default.
• W3204954837 creator A5080875885 @default.
• W3204954837 creator A5083846628 @default.
• W3204954837 date "2022-01-01" @default.
• W3204954837 modified "2023-09-27" @default.
• W3204954837 title "Methionine supplementation during a hydrogen peroxide challenge alters components of insulin signaling and antioxidant proteins in subcutaneous adipose explants from dairy cows" @default.
• W3204954837 cites W1554340035 @default.
• W3204954837 cites W1589421810 @default.
• W3204954837 cites W1593579216 @default.
• W3204954837 cites W1781304442 @default.
• W3204954837 cites W1967999992 @default.
• W3204954837 cites W1970236135 @default.
• W3204954837 cites W2001779904 @default.
• W3204954837 cites W2005868859 @default.
• W3204954837 cites W2016752484 @default.
• W3204954837 cites W2018523184 @default.
• W3204954837 cites W2026253315 @default.
• W3204954837 cites W2036522558 @default.
• W3204954837 cites W2039791996 @default.
• W3204954837 cites W2042353023 @default.
• W3204954837 cites W2043037824 @default.
• W3204954837 cites W2045938248 @default.
• W3204954837 cites W2062203982 @default.
• W3204954837 cites W2068782912 @default.
• W3204954837 cites W2072616370 @default.
• W3204954837 cites W2075842007 @default.
• W3204954837 cites W2100633524 @default.
• W3204954837 cites W2122044177 @default.
• W3204954837 cites W2149340180 @default.
• W3204954837 cites W2151673941 @default.
• W3204954837 cites W2206259120 @default.
• W3204954837 cites W2212628775 @default.
• W3204954837 cites W2278210606 @default.
• W3204954837 cites W2488522936 @default.
• W3204954837 cites W2511656868 @default.
• W3204954837 cites W2588910670 @default.
• W3204954837 cites W2607775369 @default.
• W3204954837 cites W2610510761 @default.
• W3204954837 cites W2623300580 @default.
• W3204954837 cites W2729858303 @default.
• W3204954837 cites W2766225824 @default.
• W3204954837 cites W2767767370 @default.
• W3204954837 cites W2768322370 @default.
• W3204954837 cites W2774974792 @default.
• W3204954837 cites W2775325223 @default.
• W3204954837 cites W2789424182 @default.
• W3204954837 cites W2794780581 @default.
• W3204954837 cites W2800943075 @default.
• W3204954837 cites W2807736497 @default.
• W3204954837 cites W2884164561 @default.
• W3204954837 cites W2888469706 @default.
• W3204954837 cites W2905933565 @default.
• W3204954837 cites W2917070532 @default.
• W3204954837 cites W2922193924 @default.
• W3204954837 cites W2928772040 @default.
• W3204954837 cites W2930124576 @default.
• W3204954837 cites W2961126028 @default.
• W3204954837 cites W2969414839 @default.
• W3204954837 cites W2976294779 @default.
• W3204954837 cites W2989061032 @default.
• W3204954837 cites W2999167062 @default.
• W3204954837 cites W3023887826 @default.
• W3204954837 cites W3088838762 @default.
• W3204954837 cites W3127443982 @default.
• W3204954837 cites W4211242412 @default.
• W3204954837 doi "https://doi.org/10.3168/jds.2021-20541" @default.
• W3204954837 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34635354" @default.
• W3204954837 hasPublicationYear "2022" @default.
• W3204954837 type Work @default.
• W3204954837 sameAs 3204954837 @default.
• W3204954837 citedByCount "1" @default.
• W3204954837 countsByYear W32049548372022 @default.
• W3204954837 crossrefType "journal-article" @default.
• W3204954837 hasAuthorship W3204954837A5016532599 @default.
• W3204954837 hasAuthorship W3204954837A5029951659 @default.
• W3204954837 hasAuthorship W3204954837A5040338868 @default.
• W3204954837 hasAuthorship W3204954837A5043366961 @default.
• W3204954837 hasAuthorship W3204954837A5050699503 @default.
• W3204954837 hasAuthorship W3204954837A5054909901 @default.
• W3204954837 hasAuthorship W3204954837A5068100919 @default.
• W3204954837 hasAuthorship W3204954837A5078504589 @default.
• W3204954837 hasAuthorship W3204954837A5080118809 @default.
• W3204954837 hasAuthorship W3204954837A5080875885 @default.
• W3204954837 hasAuthorship W3204954837A5083846628 @default.
• W3204954837 hasBestOaLocation W32049548371 @default.
• W3204954837 hasConcept C112446052 @default.
• W3204954837 hasConcept C126322002 @default.
• W3204954837 hasConcept C134018914 @default.

• next